Testing effectiveness (Phase 2)Study completedNCT00217594
What this trial is testing
A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Who this might be right for
Myelodysplastic Syndromes
National Heart, Lung, and Blood Institute (NHLBI) 40